NanoString Technologies, Inc. (NASDAQ:NSTG) is scheduled to be releasing its earnings data after the market closes on Tuesday, October 31st. Analysts expect NanoString Technologies to post earnings of ($0.56) per share for the quarter. NanoString Technologies has set its FY17 guidance at ($2.20)-($2.03) EPS.

NanoString Technologies (NASDAQ:NSTG) last released its quarterly earnings data on Tuesday, August 8th. The biotechnology company reported ($0.20) EPS for the quarter, topping analysts’ consensus estimates of ($0.37) by $0.17. The business had revenue of $34.59 million during the quarter, compared to the consensus estimate of $29.87 million. NanoString Technologies had a negative return on equity of 329.59% and a negative net margin of 44.28%. On average, analysts expect NanoString Technologies to post $-2.24 EPS for the current fiscal year and $-2.57 EPS for the next fiscal year.

NanoString Technologies, Inc. (NASDAQ:NSTG) traded down 3.89% during mid-day trading on Tuesday, hitting $9.40. The stock had a trading volume of 77,888 shares. NanoString Technologies, Inc. has a one year low of $9.40 and a one year high of $23.45. The firm’s 50-day moving average is $14.69 and its 200 day moving average is $16.08. The stock’s market cap is $236.92 million.

COPYRIGHT VIOLATION WARNING: This news story was first reported by American Banking News and is owned by of American Banking News. If you are reading this news story on another publication, it was illegally stolen and reposted in violation of international copyright & trademark laws. The correct version of this news story can be viewed at https://www.americanbankingnews.com/2017/10/24/nanostring-technologies-inc-nstg-set-to-announce-earnings-on-tuesday.html.

NSTG has been the topic of several research reports. Zacks Investment Research downgraded shares of NanoString Technologies from a “hold” rating to a “sell” rating in a report on Tuesday, October 17th. BidaskClub downgraded shares of NanoString Technologies from a “sell” rating to a “strong sell” rating in a report on Friday, July 28th. Cowen and Company restated a “buy” rating and set a $20.00 price objective on shares of NanoString Technologies in a report on Thursday, September 28th. Janney Montgomery Scott downgraded shares of NanoString Technologies from a “buy” rating to a “neutral” rating in a report on Thursday, October 12th. Finally, ValuEngine downgraded shares of NanoString Technologies from a “hold” rating to a “sell” rating in a report on Thursday, July 13th. Three research analysts have rated the stock with a sell rating, three have issued a hold rating and one has given a buy rating to the company. The company currently has a consensus rating of “Hold” and an average price target of $19.00.

About NanoString Technologies

NanoString Technologies, Inc develops, manufactures and sells intuitive products that unlock scientifically valuable and clinically actionable biologic information from minute amounts of tissue. The Company is engaged in the development, manufacture and commercialization of instruments, consumables and services for profiling the activity of hundreds of genes and proteins simultaneously from a single tissue sample.

Earnings History for NanoString Technologies (NASDAQ:NSTG)

Receive News & Ratings for NanoString Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoString Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.